FDA Avandia hearings panel decides fate of diabetes drug

An FDA panel is will begin hearings on Avandia today. The drug that's safety has been questioned since 2007 and could be pulled from the market. Steven Nissen has authored a study finding it could increase the risk of heart attacks. He spoke to CNN's Kiran Chetry Tuesday.